EGVI endoglucanase and nucleic acids encoding the same
US7807434B2 · kind B2 · utility
11Cited by
17References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2006 |
| Grant date | Oct 5, 2010 |
| Priority date | — |
| Expiry date | Nov 28, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E50/10
- WIPO fieldBasic materials chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a novel endoglucanase nucleic acid sequence, designated egl6, and the corresponding EGVI amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVI, recombinant EGVI proteins and methods for producing the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.